Highlander Capital Management’s Surmodics SRDX Stock Holding History

Highlander Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-996	Closed	-$18K	–	802
2016 Q1	$18K	Hold	996	–	–	0.02%	534
2015 Q4	$20K	Sell	996 -6,385	-87%	-$136K	0.02%	527
2015 Q3	$161K	Sell	7,381 -10,050	-58%	-$236K	0.15%	173
2015 Q2	$408K	Hold	17,431	–	–	0.37%	73
2015 Q1	$454K	Buy	17,431 +4,250	+32%	+$101K	0.39%	67
2014 Q4	$291K	Sell	13,181 -923	-7%	-$19.6K	0.25%	105
2014 Q3	$256K	Buy	14,104 +3,423	+32%	+$68.4K	0.24%	111
2014 Q2	$229K	Buy	10,681 +681	+7%	+$14.6K	0.21%	125
2014 Q1	$226K	Buy	+10,000	New	+$244K	0.21%	125

Other funds holding SRDX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Highlander Capital Management's SRDX Position: Q2 2016 in Review

Highlander Capital Management sold out of Surmodics (SRDX) in Q2 2016, closing a stake of 996 shares — an estimated $18K sold.

Highlander Capital Management first reported a position in SRDX in Q1 2014 and held it in 9 quarters. The position peaked at $454K in Q1 2015. 121 funds tracked by Wall St. Rank hold SRDX as of Q2 2016.

Highlander Capital Management reported no remaining Surmodics position as of Q2 2016 after selling out during the quarter.
Highlander Capital Management sold 996 Surmodics shares in Q2 2016, an estimated $18K.
Highlander Capital Management first reported a position in Surmodics in Q1 2014 and held it in 9 quarters.
Highlander Capital Management's Surmodics position peaked at $454K in Q1 2015.
121 funds tracked by Wall St. Rank held Surmodics as of Q2 2016.

Based on Highlander Capital Management's 13F filing for Q2 2016, filed 10 Aug 2016.